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ABSTRACT
Müllerian adenosarcoma is a rare, mixed tumor that can occur throughout the female genital tract, but is most commonly 
found in the uterus. Ovarian adenosarcoma is rarer and has a poorer prognosis than uterine adenosarcoma. Data on the 
clinicopathological features of ovarian adenosarcoma are limited, and, due to its rarity, the management is controversial. The 
authors report a case of a 25-year-old patient who presented with recurrent abdominal pain. Sonography and laparotomy 
showed an ovarian cyst, and pathologic examination confirmed the diagnosis of cystic low-grade adenosarcoma. The 
patient remains free of recurrence 6 months after diagnosis. The authors call attention to the differential diagnosis of 
ovarian masses, especially in young patients, and to the lack of evidence on the management of this neoplasm in the 
literature.
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CASE REPORT
A 25-year-old woman sought the gynecology 
service complaining of right lower abdominal pain 
for the past 2 months. She denied fever or other 
local inflammatory signs. She had no past history 
of comorbidities. Her gynecologic history included 
nulliparity, menarche at 13 years of age, and regular 
menstrual cycles at 28-day intervals. There was no 
reported history of cancer in her family.
The physical examination was normal except for 
a mobile mass in the right lower abdomen.
Pelvic ultrasonography revealed a right paraovarian 
cyst with a smooth outline and areas of a vaguely 
nodular thickening of the wall. The content was 
hypoechoic and a solid component was not detected. 
Serum chorionic gonadotropin was < 3 IU/L (reference 
value: < 3 IU/L) and complementary laboratory workup 
was normal. Considering the hypothesis of paraovarian 
cyst, the initial management was observation.
After 2 months of fol low-up, the patient 
complained of worsening abdominal pain, so a 
laparotomy was performed. An 8-cm simple cyst with a 
smooth surface was seen in the right ovary. A yellowish 
liquid was drained from the cyst before its dissection 
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and exeresis (simple cystectomy). On gross examination 
the uterus and fallopian tubes were normal.
Pathological examination showed a thin-walled 
(0.2–0.5 cm) cystic tumor with a smooth external 
surface. The internal surface showed multiple small 
(0.2–0.3 cm) whitish, firm, and sometimes coalescent 
vegetation. The microscopic examination showed 
a mixture of slight atypical serous or endometryoid 
epithelia with an atypical stroma. The mesenchymal 
component consisted of endometrial stromal sarcoma-
like tissue, with slight-to-moderate atypia, foci 
of fibrous appearance, and striking subepithelial 
cuffs of cellular stroma and intracystic protrusions 
(Figure 1). Some hyaline globules were present in 
the stromal component. Up to two mitotic figures 
in 10 high-power fields were counted in the stromal 
and epithelial components. There was no vascular or 
perineural invasion and the ovarian capsule was intact. 
Sarcomatous overgrowth was not detected.
The immunohistochemical panel was compatible 
with a diagnosis of low-grade ovarian adenosarcoma. 
Tumor stromal cells were positively stained with 
vimentin, smooth-muscle actin, desmin, CA125, CD10, 
progesterone receptor, and focally with estrogen 
receptor. Epithelial cells were stained with CA125, 
vimentin, progesterone, and estrogen receptors. 
Proliferation index as accessed by Ki-67 was 5% 
(Figure 2). MyoD1 and myogenin (rhabdomyoblastic 
markers) were negative.
The patient was referred to a cancer center 
where a right oophorectomy and surgical staging 
were performed. The surgery included right-salpingo-
oophorectomy, omentectomy, and peritoneal washing. 
Pathological examination showed foci of endometriosis 
in the right ovary and there was no evidence of 
malignancy. The pathological staging was pT1aN0M0 
(FIGO IA).1 No adjuvant treatment was required and 
the patient remains free of recurrence 6 months after 
first diagnosis.
Figure 1. A – Photomicrography showing papillary projections into the cyst (H&E, 12.5x); B – Papillary projections 
with dense sub-epithelial stromal cuffs (H&E; 100x); C – Mitosis in endometrial stromal sarcoma-like tissue (H&E, 
400x); D – Mitosis in epithelial cell and stromal hyaline globules (H&E; 400x).
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DISCUSSION
The first description of Müllerian adenosarcoma 
was in 1974, by Clement and Scully.2 These tumors 
are rare and are characterized by a mixture of benign 
glandular epithelium and a low-grade malignant 
sarcomatous stroma resembling that of endometrial 
stromal sarcoma.3
Adenosarcoma most commonly arises in the 
uterine endometrium, but extrauterine sites such as 
ovary, pelvic sidewall, cervix, and myometrium were 
reported previously.4-7 The main clinical manifestations 
are dependent on the location and include vaginal 
bleeding, abdominal pain, abdominal distension, 
ascites, and intestinal disorders.8 These manifestations 
are also found in many other pelvic diseases and 
physiological states, such as the menstrual period. 
Not only clinically, but also pathologically, ovarian 
adenosarcoma is difficult to diagnose.
Adenosarcomas are composed of two intermixed 
neoplastic tissues of different malignant potential: 
a benign epithelial component, with glands lined 
by benign proliferative endometrium-like cells and 
a sarcomatous component, with spindle-shaped or 
round cells that show cytologically malignant features.9 
Differential diagnosis include adenofibroma, which 
is composed of benign epithelial and mesenchymal 
elements; and carcinossarcoma, which is composed of 
distinctive and separate, but admixed, carcinomatous 
and sarcomatous elements. Both are considered mixed 
Müllerian tumors.10
The origin of adenosarcoma is not clear. While 
some authors advocate a biphasic origin, others believe 
that the tumor originates from a multipotential stem 
cell.11 Endometrioma has been suggested to be the 
histologic precursor.12 Extrauterine adenosarcoma has 
been reported in sites where endometriosis is common, 
including the pelvic sidewall, peritoneum, colon, and 
ovary.8,13 The development of adenosarcoma on a 
background of endometriosis in the ovary has also been 
reported.14-16 Besides, previous reports called attention 
to the fact that adenosarcoma most commonly arises 
Figure 2. Photomicrography of immunohistochemistry. A – CD10 staining in stromal cuff (400x); B – CA125 staining 
in epithelial cells (400x); C – Progesterone receptor staining in epithelial and stromal elements (400x); D – Desmin 
staining in stromal cells (400x).
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in the topic endometrium and rarely in intramural 
endometrium (adenomyosis).6,11 In the present case, 
endometriosis could be the precursor lesion as it was 
found after ovary removal.
Gross specimens from adenosarcomas are most 
commonly solid, but around 10% are predominantly 
cystic, similar to the present case.8,13
Ovarian adenosarcoma is generally more aggressive 
than uterine adenosarcoma and is associated with 
poorer prognosis and more advanced stage at 
presentation.8 These tumors frequently tend to recur 
locally, and distant metastases are rare.2,8 The reason 
for local recurrences could be the fact that ovarian 
adenosarcoma is susceptible to rupture and adherence 
to adjacent structures.8
Gollard et al. (1995)6 revised 15 cases of ovary 
adenosarcoma. The average patient age was 48 years; 
there were six local recurrences and only one distant 
recurrence. Eichorn et al. (2002)8 reported a series with 
40 patients diagnosed with ovarian adenosarcoma in 
which the mean age was 54 years and the ovarian mass 
was unilateral in 97% of the patients. Also, median 
time to recurrence was 2.6 years and four women 
developed distant metastasis. The 5-, 10- and 15-year 
overall survival rates were 64%, 46%, and 30%, 
respectively, and death from tumor occurred in 37.5%.8
The prognosis of early stage malignant ovarian 
cancers with capsule rupture is still controversial. In a 
recent meta-analysis involving 2382 cases of early-stage 
epithelial ovarian cancer, the intraoperative rupture 
of the capsule did not present a worse prognosis, 
compared with those whose capsules remained intact 
(Hazard ratio [HR]: 1.49; 95% confidence interval 
[CI]: 0.45–4.95). Nevertheless, the prognosis of the 
preoperative rupture is worse compared with the 
intraoperative rupture (HR: 2.63; 95% CI: 1.11–6.20).22 
On the other hand, a retrospective cohort study 
involving 161 cases of FIGO stage I ovarian epithelial 
cancers (submitted to the same staging procedure) 
showed a worse prognosis in those cases where the 
rupture of the capsule occurred, compared with those 
whose capsule remained intact (HR: 3.6; 95% CI: 
1.5–8.9; [p = 0.004]).23 
The prognosis of ovarian adenosarcomas whose 
capsules were ruptured is unknown due to the lack of 
data in the literature. The cyst puncture is a controlled 
capsule rupture, with little or no drainage of the 
cyst content into the abdominal cavity. In the case 
reported herein, we dare consider that the disease 
remained localized in the removed ovary, despite the 
puncture, considering the low malignant potential 
of this neoplasia and the restaging represented by 
the research of free neoplastic cells in the peritoneal 
lavage. 
The recommended treatment is surgical resection 
(hysterectomy and bilateral salpingo-oophorectomy). 
An attempt to establish appropriate surgical and 
pathologic staging is crucial for management.17 
Whether adjuvant chemotherapy or radiotherapy 
may play a role in avoiding disease recurrence is not 
defined in the literature. radiotherapy may play a 
role in avoiding disease recurrence is not defined in 
the literature. Data on the behavior of low-grade 
tumors are scarce regarding young patients who wish 
to have children, although age under 53 years, a 
tumoral capsule rupture, high-grade morphology, and 
a predominance of tumoral sarcomatous component 
are considered to be worse prognosis risk factors. 
This is why radical surgical treatment should be 
individualized.24
Tumors originating from the uterus showed 
median time to recurrence of 5 years, and the local 
and distant recurrences are commonly composed of 
higher-grade sarcoma than that of the mesenchymal 
component of the original neoplasm. In rare cases, the 
recurrence is biphasic.18 For these reasons, the systemic 
treatment of the recurrence or metastatic disease is 
commonly made with chemotherapy regimens directed 
to uterine and soft tissue sarcomas or carcinosarcomas, 
such as ifosfamide, cisplatin, doxorubicin, and 
dacarbazine.8,19-21 The small number of reports do 
not allow a conclusion about the efficacy of these 
drugs and how they can affect clinical outcomes for 
metastatic disease.
CONCLUSION
Adenosarcoma arising in the ovary is rare and 
carries a poorer prognosis than its uterine counterpart, 
with higher rates of recurrence. The present report 
exemplifies a case in which the patient was younger 
than the median age reported in case series of ovarian 
adenosarcoma and an uncommon cystic presentation. 
The low clinical initial suspicion made the diagnosis 
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surprising. Adenosarcoma should always be considered 
as a differential diagnosis in patients with solid or 
cystic pelvic masses, particularly in those with a history 
of endometriosis. The treatment consists of surgical 
resection and the role of chemotherapy or radiation 
is not clear. Clinical trials for ovarian adenosarcoma 
would be beneficial but multicentric studies may be 
necessary due to the rarity of this disease.
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